在临床心脏病学中使用可穿戴设备测量峰值耗氧量:病例报告和文献综述。

IF 1.9 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
Gabriella Bayshtok, Shmuel Tiosano, Ariel Furer
{"title":"在临床心脏病学中使用可穿戴设备测量峰值耗氧量:病例报告和文献综述。","authors":"Gabriella Bayshtok,&nbsp;Shmuel Tiosano,&nbsp;Ariel Furer","doi":"10.2196/45504","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Oxygen consumption is an important index to evaluate in cardiac patients, particularly those with heart failure, and is measured in the setting of advanced cardiopulmonary exercise testing. However, technological advances now allow for the estimation of this parameter in many consumer and medical-grade wearable devices, making it available for the medical provider at the initial evaluation of patients. We report a case of an apparently healthy male aged 40 years who presented for evaluation due to an Apple Watch (Apple Inc) notification of low cardiac fitness. This alert triggered a thorough workup, revealing a diagnosis of familial nonischemic cardiomyopathy with severely reduced left ventricular systolic function. While the use of wearable devices for the measurement of oxygen consumption and related parameters is promising, further studies are needed for validation.</p><p><strong>Objective: </strong>The aim of this report is to investigate the potential utility of wearable devices as a screening and risk stratification tool for cardiac fitness for the general population and those with increased cardiovascular risk, particularly through the measurement of peak oxygen consumption (VO<sub>2</sub>). We discuss the possible advantages of measuring oxygen consumption using wearables and propose its integration into routine patient evaluation and follow-up processes. With the current evidence and limitations, we encourage researchers and clinicians to explore bringing wearable devices into clinical practice.</p><p><strong>Methods: </strong>The case was identified at Sheba Medical Center, and the patient's cardiac fitness was monitored through an Apple Watch Series 6. The patient underwent a comprehensive cardiac workup following his presentation. Subsequently, we searched the literature for articles relating to the clinical utility of peak VO<sub>2</sub> monitoring and available wearable devices.</p><p><strong>Results: </strong>The Apple Watch data provided by the patient demonstrated reduced peak VO<sub>2</sub>, a surrogate index for cardiac fitness, which improved after treatment initiation. A cardiological workup confirmed familial nonischemic cardiomyopathy with severely reduced left ventricular systolic function. A review of the literature revealed the potential clinical benefit of peak VO<sub>2</sub> monitoring in both cardiac and noncardiac scenarios. Additionally, several devices on the market were identified that could allow for accurate oxygen consumption measurement; however, future studies and approval by the Food and Drug Administration (FDA) are still necessary.</p><p><strong>Conclusions: </strong>This case report highlights the potential utility of peak VO<sub>2</sub> measurements by wearable devices for early identification and screening of cardiac fitness for the general population and those at increased risk of cardiovascular disease. The integration of wearable devices into routine patient evaluation may allow for earlier presentation in the diagnostic workflow. Cardiac fitness can be serially measured using the wearable device, allowing for close monitoring of functional capacity parameters. Devices need to be used with caution, and further studies are warranted.</p>","PeriodicalId":51757,"journal":{"name":"Interactive Journal of Medical Research","volume":null,"pages":null},"PeriodicalIF":1.9000,"publicationDate":"2023-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466150/pdf/","citationCount":"0","resultStr":"{\"title\":\"Use of Wearable Devices for Peak Oxygen Consumption Measurement in Clinical Cardiology: Case Report and Literature Review.\",\"authors\":\"Gabriella Bayshtok,&nbsp;Shmuel Tiosano,&nbsp;Ariel Furer\",\"doi\":\"10.2196/45504\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Oxygen consumption is an important index to evaluate in cardiac patients, particularly those with heart failure, and is measured in the setting of advanced cardiopulmonary exercise testing. However, technological advances now allow for the estimation of this parameter in many consumer and medical-grade wearable devices, making it available for the medical provider at the initial evaluation of patients. We report a case of an apparently healthy male aged 40 years who presented for evaluation due to an Apple Watch (Apple Inc) notification of low cardiac fitness. This alert triggered a thorough workup, revealing a diagnosis of familial nonischemic cardiomyopathy with severely reduced left ventricular systolic function. While the use of wearable devices for the measurement of oxygen consumption and related parameters is promising, further studies are needed for validation.</p><p><strong>Objective: </strong>The aim of this report is to investigate the potential utility of wearable devices as a screening and risk stratification tool for cardiac fitness for the general population and those with increased cardiovascular risk, particularly through the measurement of peak oxygen consumption (VO<sub>2</sub>). We discuss the possible advantages of measuring oxygen consumption using wearables and propose its integration into routine patient evaluation and follow-up processes. With the current evidence and limitations, we encourage researchers and clinicians to explore bringing wearable devices into clinical practice.</p><p><strong>Methods: </strong>The case was identified at Sheba Medical Center, and the patient's cardiac fitness was monitored through an Apple Watch Series 6. The patient underwent a comprehensive cardiac workup following his presentation. Subsequently, we searched the literature for articles relating to the clinical utility of peak VO<sub>2</sub> monitoring and available wearable devices.</p><p><strong>Results: </strong>The Apple Watch data provided by the patient demonstrated reduced peak VO<sub>2</sub>, a surrogate index for cardiac fitness, which improved after treatment initiation. A cardiological workup confirmed familial nonischemic cardiomyopathy with severely reduced left ventricular systolic function. A review of the literature revealed the potential clinical benefit of peak VO<sub>2</sub> monitoring in both cardiac and noncardiac scenarios. Additionally, several devices on the market were identified that could allow for accurate oxygen consumption measurement; however, future studies and approval by the Food and Drug Administration (FDA) are still necessary.</p><p><strong>Conclusions: </strong>This case report highlights the potential utility of peak VO<sub>2</sub> measurements by wearable devices for early identification and screening of cardiac fitness for the general population and those at increased risk of cardiovascular disease. The integration of wearable devices into routine patient evaluation may allow for earlier presentation in the diagnostic workflow. Cardiac fitness can be serially measured using the wearable device, allowing for close monitoring of functional capacity parameters. Devices need to be used with caution, and further studies are warranted.</p>\",\"PeriodicalId\":51757,\"journal\":{\"name\":\"Interactive Journal of Medical Research\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2023-08-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466150/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Interactive Journal of Medical Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2196/45504\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Interactive Journal of Medical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2196/45504","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

摘要

背景:耗氧量是评价心脏病患者,特别是心力衰竭患者的一个重要指标,可在高级心肺运动试验中测量。然而,技术进步现在允许在许多消费级和医疗级可穿戴设备中估计该参数,使医疗提供者可以在对患者进行初步评估时使用该参数。我们报告一例表面上健康的40岁男性,由于Apple Watch (Apple Inc .)的低心脏健康通知而前来评估。这一警报引发了彻底的检查,诊断为家族性非缺血性心肌病,左心室收缩功能严重降低。虽然使用可穿戴设备测量氧气消耗和相关参数是有希望的,但需要进一步的研究来验证。目的:本报告的目的是研究可穿戴设备作为普通人群和心血管风险增加人群心脏健康筛查和风险分层工具的潜在用途,特别是通过测量峰值耗氧量(VO2)。我们讨论了使用可穿戴设备测量氧气消耗的可能优势,并建议将其整合到常规患者评估和随访过程中。鉴于目前的证据和局限性,我们鼓励研究人员和临床医生探索将可穿戴设备带入临床实践。方法:该病例在Sheba医疗中心确诊,并通过Apple Watch Series 6监测患者的心脏健康状况。病人在就诊后接受了全面的心脏检查。随后,我们检索了有关VO2峰值监测和可用可穿戴设备的临床应用的文献。结果:患者提供的Apple Watch数据显示,VO2峰值(心脏健康的替代指标)降低,在治疗开始后有所改善。心脏病检查证实家族性非缺血性心肌病伴左心室收缩功能严重降低。对文献的回顾揭示了在心脏和非心脏情况下监测峰值VO2的潜在临床益处。此外,市场上的几种设备被确定可以允许准确的耗氧量测量;然而,未来的研究和批准的食品和药物管理局(FDA)仍然是必要的。结论:本病例报告强调了可穿戴设备的峰值VO2测量在普通人群和心血管疾病风险增加人群的早期识别和心脏健康筛查中的潜在效用。将可穿戴设备集成到常规患者评估中可以在诊断工作流程中更早地呈现。心脏健康可以使用可穿戴设备连续测量,允许密切监测功能容量参数。设备需要谨慎使用,进一步的研究是有必要的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Use of Wearable Devices for Peak Oxygen Consumption Measurement in Clinical Cardiology: Case Report and Literature Review.

Use of Wearable Devices for Peak Oxygen Consumption Measurement in Clinical Cardiology: Case Report and Literature Review.

Use of Wearable Devices for Peak Oxygen Consumption Measurement in Clinical Cardiology: Case Report and Literature Review.

Background: Oxygen consumption is an important index to evaluate in cardiac patients, particularly those with heart failure, and is measured in the setting of advanced cardiopulmonary exercise testing. However, technological advances now allow for the estimation of this parameter in many consumer and medical-grade wearable devices, making it available for the medical provider at the initial evaluation of patients. We report a case of an apparently healthy male aged 40 years who presented for evaluation due to an Apple Watch (Apple Inc) notification of low cardiac fitness. This alert triggered a thorough workup, revealing a diagnosis of familial nonischemic cardiomyopathy with severely reduced left ventricular systolic function. While the use of wearable devices for the measurement of oxygen consumption and related parameters is promising, further studies are needed for validation.

Objective: The aim of this report is to investigate the potential utility of wearable devices as a screening and risk stratification tool for cardiac fitness for the general population and those with increased cardiovascular risk, particularly through the measurement of peak oxygen consumption (VO2). We discuss the possible advantages of measuring oxygen consumption using wearables and propose its integration into routine patient evaluation and follow-up processes. With the current evidence and limitations, we encourage researchers and clinicians to explore bringing wearable devices into clinical practice.

Methods: The case was identified at Sheba Medical Center, and the patient's cardiac fitness was monitored through an Apple Watch Series 6. The patient underwent a comprehensive cardiac workup following his presentation. Subsequently, we searched the literature for articles relating to the clinical utility of peak VO2 monitoring and available wearable devices.

Results: The Apple Watch data provided by the patient demonstrated reduced peak VO2, a surrogate index for cardiac fitness, which improved after treatment initiation. A cardiological workup confirmed familial nonischemic cardiomyopathy with severely reduced left ventricular systolic function. A review of the literature revealed the potential clinical benefit of peak VO2 monitoring in both cardiac and noncardiac scenarios. Additionally, several devices on the market were identified that could allow for accurate oxygen consumption measurement; however, future studies and approval by the Food and Drug Administration (FDA) are still necessary.

Conclusions: This case report highlights the potential utility of peak VO2 measurements by wearable devices for early identification and screening of cardiac fitness for the general population and those at increased risk of cardiovascular disease. The integration of wearable devices into routine patient evaluation may allow for earlier presentation in the diagnostic workflow. Cardiac fitness can be serially measured using the wearable device, allowing for close monitoring of functional capacity parameters. Devices need to be used with caution, and further studies are warranted.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Interactive Journal of Medical Research
Interactive Journal of Medical Research MEDICINE, RESEARCH & EXPERIMENTAL-
自引率
0.00%
发文量
45
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信